ClinicalTrials.gg
Status unknownNCT04660006Updated Dec 9, 2020

Diabetic Retinopathy and OCT-A Changes Post-cataract Surgery

An observational study in Cataract, Diabetic Retinopathy and Macular Edema Due to Diabetes Mellitus, sponsored by Uptown Eye Specialists. Status unknown at 1 site in Canada. Per ClinicalTrials.gov, last updated 2020-12-09.

Sponsored by Uptown Eye Specialists · Observational

How we know

The sponsor has not verified this record recently (last verified Dec 2020), so the status shown — last known as Enrolling by invitation — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
170
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 33 studies in Cataract with a site in Canada — 3 open to participants now, 3 under way, none of them phase 3. Cataract · Canada.

Planned enrollment
3rd of 10
170 · median 123
Started
2019
with 3 others
Observational
10 of 33
1 open now
Registered
23rd of 33
by date
Lead sponsor
5 of 33
Uptown Eye Specialists

Among the 33 studies in Cataract with a site in Canada, this one is the 3rd largest by planned enrollment of the 10 observational ones that give a count, is one of 4 that started in 2019, is one of 10 observational ones, and was the 23rd registered.

Cataract

1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.

Browse Cataract studies →

Open to participants now

3 of the 33 studies in Cataract with a site in Canada are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 33 studies in Cataract with a site in Canada, or all of them as a file.
02

Study summary

The purpose of this study is to use optical coherence tomography angiography (OCT-A) to compare retinal vasculature after uncomplicated cataract surgery in patients with and without diabetic retinopathy.

Read the detailed description

Patients undergoing cataract surgery who provided informed consent were enrolled in the study. There were three comparison groups: control, diabetic retinopathy (DR) and diabetic macular edema (DME) groups. Optical coherence tomography angiography (OCT-A) scans measuring retinal thickness, vessel density, perfusion density, and foveal avascular zone were obtained at baseline and postoperative week one, month one and month three.

03

Conditions studied

  • Cataract
  • Diabetic Retinopathy
  • Macular Edema Due to Diabetes Mellitus

Keywords

  • Optical Coherence Tomography Angiography
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants selected from Uptown Eye Specialists, an eye care clinic, at two sites in Brampton, Ontario, Canada and Vaughan, Ontario, Canada.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients at Uptown Eye Specialists undergoing uneventful cataract surgery who have provided to the study.

Exclusion criteria

Exclusion Criteria:

  • Other ocular co-morbidities such as axial length \< 22.0 mm or > 25.0 mm, previous ocular surgeries, previous history of uveitis, previous ocular trauma, cornea pathologies or glaucoma, intraocular pressures over 22 mmHg
  • In groups 1 and 2: previous retinal laser treatments
  • OCT-A signal strength \< 6
  • Use of multifocal intraocular lens
  • Second eye (if first eye recruited)
  • In Group 1: No diabetes mellitus as past medical history
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
170 participants (estimated)
Patient registry
No

Groups and cohorts

  • Control

    Patients undergoing uneventful cataract surgery with no retinal vascular disease.

    Procedure: Cataract surgery

  • Diabetic Retinopathy (DR)

    Patients with non-proliferative diabetic retinopathy with no diabetic macular edema treatment in the 6 months prior to uneventful cataract surgery.

    Procedure: Cataract surgery

  • Diabetic Macular Edema (DME)

    Patients with diabetic macular edema undergoing active Anti-VEGF treatment (within the last 3 months) undergoing uneventful cataract surgery.

    Procedure: Cataract surgery

Interventions

  • ProcedureCataract surgery

    Patients undergoing uneventful cataract surgery were recruited to this study if they met the inclusion criteria of the three groups. Postoperative retinal vasculature measures, as recorded by the optical coherence tomography angiography imaging technique, were compared to baseline measures.

06

What researchers measure

Primary outcomes

  1. Change from baseline of retinal vessel density up to 3 months post-cataract surgery.

    Optical coherence tomography angiography (OCT-A) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements for retinal vessel density to be compared between groups and time.

    Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)

  2. Change from baseline of retinal perfusion density up to 3 months post-cataract surgery.

    Optical coherence tomography angiography (OCT-A) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements for retinal perfusion density to be compared between groups and time.

    Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)

  3. Change from baseline of foveal avascular zone up to 3 months post-cataract surgery.

    Optical coherence tomography angiography (OCT-A) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements for foveal avascular zone (FAZ), particularly FAZ area, perimeter, and circularity index, to be compared between groups and time.

    Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)

  4. Change from baseline of retinal thickness up to 3 months post-cataract surgery.

    Optical coherence tomography (OCT) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements of retinal thickness, particularly, central subfield and average macular cube thickness, to be compared between groups and time.

    Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)

Secondary outcomes

  1. Development of new cystoid macular edema

    New cases of cystoid macular edema (a potential side effect of cataract surgery) are to be recorded to determine if there are preoperative risk factors for development of cystoid macular edema post-cataract surgery.

    Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)

07

Study locations

1 site
  • Uptown Eye Speicialists
    Brampton, Ontario L6Y0P6, Canada
08

References and documents

Publications

  • Eriksson U, Alm A, Bjarnhall G, Granstam E, Matsson AW. Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls. Graefes Arch Clin Exp Ophthalmol. 2011 Mar;249(3):349-59. doi: 10.1007/s00417-010-1484-9. Epub 2010 Sep 9. PubMed 20827486 ↗
  • Yu S, Frueh BE, Steinmair D, Ebneter A, Wolf S, Zinkernagel MS, Munk MR. Cataract significantly influences quantitative measurements on swept-source optical coherence tomography angiography imaging. PLoS One. 2018 Oct 2;13(10):e0204501. doi: 10.1371/journal.pone.0204501. eCollection 2018. PubMed 30278057 ↗
  • Zhao Z, Wen W, Jiang C, Lu Y. Changes in macular vasculature after uncomplicated phacoemulsification surgery: Optical coherence tomography angiography study. J Cataract Refract Surg. 2018 Apr;44(4):453-458. doi: 10.1016/j.jcrs.2018.02.014. Epub 2018 Apr 25. PubMed 29705010 ↗
  • Sorour O, Arya M, Waheed N. New findings and challenges in OCT angiography for diabetic retinopathy. Annals of Eye Science. 2018; 3(8): 44-54.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2019 (actual). Primary completion is estimated for Jul 2021, 26 months after the start.

Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's planned 26 months is above that.

Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 2, 2020
First posted
Dec 9, 2020
StartActual
May 27, 2019
Primary completionEst.
Jul 2021
CompletionEst.
Jul 2021
Last update
Dec 9, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04660006
Lead sponsor
Uptown Eye Specialists
Responsible party
Sponsor
First posted
Dec 9, 2020
Start date
May 27, 2019
Primary completion
Jul 2021 (estimated)
Completion
Jul 2021 (estimated)
Last update
Dec 9, 2020

Study contacts

Hannah H Chiu, MD, FRCSC
principal investigator · Uptown Eye Specialists

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion